Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationTransplantation ConditioningHematopoietic Stem Cell MobilizationHematologic NeoplasmsGraft vs Host DiseaseMelphalanCombined Modality TherapyGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisBlood Component RemovalMultiple MyelomaTreatment OutcomeCyclophosphamideBusulfanMyeloablative AgonistsAntineoplastic Combined Chemotherapy ProtocolsBone Marrow TransplantationGraft SurvivalStem CellsHematopoietic Stem CellsLymphoma, Non-HodgkinRemission InductionRecurrenceCytomegalovirus InfectionsEtoposideHistocompatibility TestingThiotepaAntineoplastic Agents, AlkylatingRetrospective StudiesSalvage TherapyTransplantation ChimeraTissue DonorsCytophagocytosisCarmustineDisease-Free SurvivalCord Blood Stem Cell TransplantationIfosfamideHodgkin DiseaseVincristineAmyloidosisCytarabineSurvival RateHematopoiesisRoseolovirus InfectionsWhole-Body IrradiationSurvival AnalysisNeoplasmsTime FactorsHistocompatibilityImmunosuppressive AgentsAspergillosisVidarabineInfectionGraft vs Leukemia EffectLeukemia, Myeloid, AcuteLeukemiaCytomegalovirusLymphoma, T-CellFollow-Up StudiesDoxorubicinPlatelet CountAntineoplastic AgentsPOEMS SyndromeTransplantation, IsogeneicFatal OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrednisoneProspective StudiesCarboplatinMyelodysplastic SyndromesLymphocyte DepletionDexamethasoneAnemia, AplasticLymphomaOpportunistic InfectionsRecombinant ProteinsBone Marrow PurgingBlood Cell CountPrecursor Cell Lymphoblastic Leukemia-LymphomaFeasibility StudiesT-LymphocytesHematologic DiseasesBlood CellsEmbryonic Stem CellsGraft vs Tumor EffectImmunophenotypingHLA AntigensImmunosuppressionPrognosisCyclosporineMesenchymal Stem Cell TransplantationAdult Stem CellsSiblingsBlood DonorsFlow Cytometry